{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:31:17Z","timestamp":1766547077876,"version":"3.48.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 AI168209"],"award-info":[{"award-number":["R01 AI168209"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127548","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:16:15Z","timestamp":1753542975000},"page":"127548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tinnitus risk after COVID-19 XBB.1.5 vaccination: A self-controlled case series study"],"prefix":"10.1016","volume":"62","author":[{"given":"Stanley","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vennis","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Holmquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia J.","family":"Bruxvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.127548_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to august 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127548_bb0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127548_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18512","article-title":"Myocarditis or pericarditis following mRNA COVID-19 vaccination","volume":"5","author":"Weintraub","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127548_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004245","article-title":"Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: a self-controlled case series analysis in England","volume":"20","author":"Stowe","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.127548_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.951314","article-title":"Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis","volume":"9","author":"Voleti","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127548_bb0030","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2024.16380","article-title":"Long-term prognosis of patients with myocarditis attributed to COVID-19 mRNA vaccination, SARS-CoV-2 infection, or conventional etiologies","volume":"332","author":"Semenzato","year":"2024","journal-title":"JAMA"},{"author":"World Health Organization (WHO)","key":"10.1016\/j.vaccine.2025.127548_bb0035"},{"author":"Food and Drug Administration (FDA)","key":"10.1016\/j.vaccine.2025.127548_bb0040"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127548_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127548_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127548_bb0060","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00415-024-12186-7","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19 vaccination: a systematic review and meta-analysis","volume":"271","author":"Censi","year":"2024","journal-title":"J Neurol"},{"issue":"43","key":"10.1016\/j.vaccine.2025.127548_bb0065","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.15585\/mmwr.mm7043e2","article-title":"COVID-19 vaccination and non-COVID-19 mortality risk \u2013 seven integrated health care organizations, United States, December 14, 2020\u2013July 31, 2021","volume":"70","author":"Xu","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127548_bb0070","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.vaccine.2022.12.036","article-title":"A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination","volume":"41","author":"Xu","year":"2023","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127548_bb0075","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2024.02.032","article-title":"Mortality risk after COVID-19 vaccination: a self-controlled case series study","volume":"42","author":"Xu","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127548_bb0080","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-023-36494-0","article-title":"Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England","volume":"14","author":"Nafilyan","year":"2023","journal-title":"Nat Commun"},{"issue":"31","key":"10.1016\/j.vaccine.2025.127548_bb0085","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1016\/j.vaccine.2023.06.005","article-title":"Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021\u2013January 2022","volume":"41","author":"de Gier","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127548_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/14992027.2021.1931969","article-title":"Tinnitus following COVID-19 vaccination: report of three cases","volume":"61","author":"Parrino","year":"2022","journal-title":"Int J Audiol"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127548_bb0095","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127548_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/qjmed\/hcac124","article-title":"Pfizer-BioNTech COVID-19 vaccine-associated tinnitus and treatment with transcranial magnetic stimulation","volume":"115","author":"Chen","year":"2022","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127548_bb0105","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamaoto.2016.1700","article-title":"Prevalence, severity, exposures, and treatment patterns of tinnitus in the United States","volume":"142","author":"Bhatt","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127548_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104448","article-title":"Tinnitus after COVID-19 vaccination: findings from the vaccine adverse event reporting system and the vaccine safety datalink","volume":"45","author":"Yih","year":"2024","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127548_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2023.103863","article-title":"Tinnitus cases after COVID-19 vaccine administration, one institution\u2019s observations","volume":"44","author":"Lin","year":"2023","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.vaccine.2025.127548_bb0120","article-title":"COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2025.127548_bb0125","article-title":"SARS-CoV-2 vaccine-associated tinnitus: a review","volume":"75","author":"Ahmed","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127548_bb0130","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2024.02.051","article-title":"Audiovestibular adverse events following COVID-19 vaccinations","volume":"42","author":"Shetty","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127548_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2307\/2533328","article-title":"Relative incidence estimation from case series for vaccine safety evaluation","volume":"51","author":"Farrington","year":"1995","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2025.127548_bb0140","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127548_bb0145","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127548_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.vaccine.2025.127548_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/biostatistics\/kxn013","article-title":"Case series analysis for censored, perturbed, or curtailed post-event exposures","volume":"10","author":"Farrington","year":"2009","journal-title":"Biostatistics"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127548_bb0160","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.vaccine.2024.03.043","article-title":"A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases","volume":"42","author":"Schultze","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127548_bb0165","article-title":"Ischemic stroke after bivalent COVID-19 vaccination: self-controlled case series study","volume":"25","author":"Xu","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2025.127548_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1508607","article-title":"Tinnitus and COVID-19: effect of infection, vaccination, and the pandemic","volume":"12","author":"Tai","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2025.127548_bb0180","doi-asserted-by":"crossref","first-page":"1509444","DOI":"10.3389\/fauot.2025.1509444","article-title":"Impact of COVID-19 vaccination on tinnitus onset and severity: a comprehensive survey study","volume":"3","author":"Yellamsetty","year":"2025","journal-title":"Front Audiol Otol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127548_bb0185","article-title":"Shedding light on SARS-CoV-2, COVID-19, COVID-19 vaccination, and auditory symptoms: causality or spurious conjunction?","volume":"22","author":"Saunders","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2025.127548_bb0195","article-title":"Effectiveness of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination against SARS-CoV-2 omicron XBB and BA.2.86\/JN.1 lineage hospitalization and a comparison of clinical severity-IVY network, 26 hospitals, October 18, 2023-march 9, 2024","volume":"6","author":"Ma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127548_bb0200","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jamia\/ocz148","article-title":"How and when informative visit processes can bias inference when using electronic health records data for clinical research","volume":"26","author":"Goldstein","year":"2019","journal-title":"J Am Med Inform Assoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500845X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500845X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:28:42Z","timestamp":1766546922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500845X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"alternative-id":["S0264410X2500845X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127548","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tinnitus risk after COVID-19 XBB.1.5 vaccination: A self-controlled case series study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127548"}}